{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:05:43Z","timestamp":1793937943881,"version":"4.8.0"},"reference-count":59,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":314,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Genomics Research and Development Initiative-Antimicrobial Resistance"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p><jats:italic>Campylobacter<\/jats:italic> spp. are one of the most common causes of bacterial gastroenteritis in Canada and worldwide. Fluoroquinolones are often used to treat complicated human campylobacteriosis and strains of <jats:italic>Campylobacter<\/jats:italic> spp. resistant to these drugs are emerging along the food chain. A scoping review was conducted to summarise how human (fluoro)quinolone-resistant (FQR; quinolones including fluoroquinolones) <jats:italic>Campylobacter<\/jats:italic> spp. infections are characterised in the literature by describing how burden of illness (BOI) associated with FQR is measured and reported, describing the variability in reporting of study characteristics, and providing a narrative review of literature that compare BOI measures of FQR <jats:italic>Campylobacter<\/jats:italic> spp. infections to those with susceptible infections. The review identified 26 studies that yielded many case reports, a lack of recent literature and a lack of Canadian data. Studies reported 26 different BOI measures and the most common were hospitalisation, diarrhoea, fever and duration of illness. There were mixed results as BOI measures reported in literature were inconsistently defined and there were limited comparisons between resistant and susceptible infections. This presents a challenge when attempting to assess the magnitude of the BOI due to FQR <jats:italic>Campylobacter<\/jats:italic> spp., highlighting the need for more research in this area.<\/jats:p>","DOI":"10.1017\/s095026882200139x","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T10:00:30Z","timestamp":1668160830000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":6,"title":["Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant <i>Campylobacter<\/i> spp. infections \u2013 a scoping review"],"prefix":"10.1017","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9141-1224","authenticated-orcid":false,"given":"M. J.","family":"Isada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4476-8957","authenticated-orcid":false,"given":"M.","family":"Reist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8966-2980","authenticated-orcid":false,"given":"M. C.","family":"MacKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4988-6458","authenticated-orcid":false,"given":"F. C.","family":"Uhland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3171-2575","authenticated-orcid":false,"given":"K. M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0347-9734","authenticated-orcid":false,"given":"K.","family":"Gibbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-9524","authenticated-orcid":false,"given":"E. J.","family":"Parmley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-0961","authenticated-orcid":false,"given":"C. A.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"S095026882200139X_ref42","first-page":"96","article-title":"Campylobacter jejuni bacteremia in Italian pediatric patients with acute lymphoblastic leukemia: report of two cases","volume":"43","author":"Martora","year":"2020","journal-title":"New Microbiologica"},{"key":"S095026882200139X_ref43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12879-020-4929-8","article-title":"Two-sided femoral Campylobacter jejuni oseteomyelitis in a patient with acquired hypogammaglobulinemia: a case report","volume":"20","author":"Hartman","year":"2020","journal-title":"BMC Infectious Diseases"},{"key":"S095026882200139X_ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7189\/jogh.06.010306","article-title":"Global disease burden due to antibiotic resistance \u2013 state of the evidence","volume":"6","author":"Woolhouse","year":"2016","journal-title":"Journal of Global Health"},{"key":"S095026882200139X_ref2","unstructured":"2. World Health Organization (2015) WHO estimates of the global burden of foodborne diseases. Available at https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/199350\/9789241565165_eng.pdf (Accessed 13 December 2021)."},{"key":"S095026882200139X_ref44","first-page":"662","article-title":"Fatal Campylobacter jejuni ileocolitis","volume":"108","author":"Magaz-Martinez","year":"2016","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"key":"S095026882200139X_ref29","volume-title":"Methods in Epidemiologic Research","author":"Dohoo","year":"2012"},{"key":"S095026882200139X_ref46","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/BF01974004","article-title":"Urinary tract infection caused by quinolone-resistant Campylobacter coli","volume":"13","author":"Pascual","year":"1994","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"S095026882200139X_ref19","unstructured":"19. Public Health Agency of Canada (2020) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2018: Integrated Findings. Available at https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/surveillance\/canadian-integrated-program-antimicrobial-resistance-surveillance-cipars\/cipars-reports\/2018-annual-report-integrated-findings\/2018-annual-report-integrated-findings.pdf (Accessed 8 March 2022)."},{"key":"S095026882200139X_ref48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/381270","article-title":"Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype Typhimurium infections","volume":"189","author":"Martin","year":"2004","journal-title":"The Journal of Infectious Diseases"},{"key":"S095026882200139X_ref15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.envint.2018.04.041","article-title":"Critical knowledge gaps and research needs related to the environmental dimensions of antimicrobial resistance","volume":"117","author":"Larsson","year":"2018","journal-title":"Environment International"},{"key":"S095026882200139X_ref50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/427263","article-title":"Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations","volume":"191","author":"Varma","year":"2005","journal-title":"The Journal of Infectious Diseases"},{"key":"S095026882200139X_ref38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1469-0691.2008.02657.x","article-title":"Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates","volume":"15","author":"Feodoroff","year":"2008","journal-title":"Clinical Microbiology and Infection"},{"key":"S095026882200139X_ref26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Annals of internal medicine"},{"key":"S095026882200139X_ref17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijmm.2019.04.003","article-title":"Enhanced microbiological surveillance reveals that temporal case clusters contribute to the high rates of campylobacteriosis in a model agroecosystem","volume":"309","author":"Inglis","year":"2020","journal-title":"International Journal of Medical Microbiology"},{"key":"S095026882200139X_ref35","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3201\/eid1006.030669","article-title":"Quinolone-resistant Campylobacter infections in Denmark: risk factors and clinical consequences","volume":"10","author":"Engberg","year":"2004","journal-title":"Emerging Infectious Diseases"},{"key":"S095026882200139X_ref33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/423282","article-title":"Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter infection","volume":"190","author":"Nelson","year":"2004","journal-title":"The Journal of Infectious Diseases"},{"key":"S095026882200139X_ref3","unstructured":"3. Public Health Agency of Canada (2018) Campylobacteriosis (Campylobacter). Available at https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/campylobacteriosis-campylobacter.html (Accessed 13 December 2021)."},{"key":"S095026882200139X_ref23","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaa104","article-title":"Measures used to assess the burden of ESBL-producing Escherichia coli infections in humans: a scoping review","volume":"3","author":"McDonald","year":"2021","journal-title":"JAC Antimicrobial Resistance"},{"key":"S095026882200139X_ref21","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-018-0336-y","article-title":"Estimating the burden of antimicrobial resistance: a systematic literature review","volume":"7","author":"Naylor","year":"2018","journal-title":"Antimicrobial Resistance and Infection Control"},{"key":"S095026882200139X_ref27","unstructured":"27. World Health Organization (WHO) (2019) ATC\/DDD Index 2020. Accessed 10 January 2022."},{"key":"S095026882200139X_ref6","unstructured":"6. Health Canada (2017) Summary safety review \u2013 fluoroquinolones \u2013 assessing the potential risk of persistent and disabling side effects. Available at https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/safety-reviews\/summary-safety-review-fluoroquinolones-assessing-potential-risk-persistent-disabling-effects.html (Accessed 13 December 2021)."},{"key":"S095026882200139X_ref10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/17460913.4.2.189","article-title":"Antibiotic resistance in Campylobacter: emergence, transmission, and persistence","volume":"4","author":"Luangtongkum","year":"2009","journal-title":"Future Microbiology"},{"key":"S095026882200139X_ref16","unstructured":"16. Government of Canada (2020) National Enteric Surveillance Program Annual Summary 2019: Public Health Agency of Canada. Available at https:\/\/publications.gc.ca\/collections\/collection_2021\/aspc-phac\/HP37-15-2019-eng.pdf (Accessed 22 June 2022."},{"key":"S095026882200139X_ref22","unstructured":"22. Public Health Agency of Canada (2017) The economic burden of illness in Canada, 2010. Available at https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/science-research-data\/economic-burden-illness-canada-2010.html#appx (Accessed 8 March 2022)."},{"key":"S095026882200139X_ref59","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jiac.2021.01.012","article-title":"Sequential breast implant infections due to Campylobacter fetus subsp. fetus","volume":"27","author":"Nishikubo","year":"2021","journal-title":"Journal of Infection and Chemotherapy"},{"key":"S095026882200139X_ref24","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/j.1475-6773.2008.00892.x","article-title":"Measuring hospital inefficiency: the effects of controlling for quality and patient burden of illness","volume":"43","author":"Mutter","year":"2008","journal-title":"Health Services Research"},{"key":"S095026882200139X_ref45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0196-4399(97)87666-0","article-title":"Bacteremia due to fluoroquinolone-resistant Campylobacter jejuni in an immunocompetent child","volume":"19","author":"Tajada","year":"1997","journal-title":"Clinical Microbiology Newsletter"},{"key":"S095026882200139X_ref52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3201\/eid1905.121344","article-title":"Campylobacter coli outbreak in men who have sex with men, Quebec, Canada, 2010\u20132011","volume":"19","author":"Gaudreau","year":"2013","journal-title":"Emerging Infectious Diseases"},{"key":"S095026882200139X_ref12","unstructured":"12. Food and Drug Administration (FDA) (2005) Withdrawal of Enrofloxacin for poultry. Available at https:\/\/www.fda.gov\/animal-veterinary\/recalls-withdrawals\/withdrawal-enrofloxacin-poultry (Accessed 8 March 2022)."},{"key":"S095026882200139X_ref39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.67.533","article-title":"An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection","volume":"67","author":"Sanders","year":"2002","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"S095026882200139X_ref5","first-page":"99","volume-title":"Campylobacter","author":"Blaser","year":"2008"},{"key":"S095026882200139X_ref14","unstructured":"14. Public Health Agency of Canada (2016) Canadian Antimicrobial Resistance Surveillance System Report 2016. Available at https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/drugs-health-products\/canadian-antimicrobial-resistance-surveillance-system-report-2016.html?_ga=1.147673527.1854701138.1479503419 (Accessed 8 March 2022)."},{"key":"S095026882200139X_ref40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/00002030-199508000-00008","article-title":"Campylobacter infections in HIV-infected patients: clinical and bacteriological features","volume":"9","author":"Molina","year":"1995","journal-title":"AIDS"},{"key":"S095026882200139X_ref25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"International Journal of Social Research Methodology"},{"key":"S095026882200139X_ref34","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199905203402001","article-title":"Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992\u20131998","volume":"340","author":"Smith","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"S095026882200139X_ref7","unstructured":"7. Health Canada (2009) Categorization of antimicrobial drugs based on importance in human medicine. Available at https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/veterinary-drugs\/antimicrobial-resistance\/categorization-antimicrobial-drugs-based-importance-human-medicine.html (Accessed 13 December 2021."},{"key":"S095026882200139X_ref8","unstructured":"8. World Health Organization (2019) Critically important antimicrobials for human medicine \u2013 6th revision. Geneva. Report No.: ISBN: 978-92-4-151552-8. Accessed 13 December 2021."},{"key":"S095026882200139X_ref49","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/424570","article-title":"Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium","volume":"190","author":"Helms","year":"2004","journal-title":"The Journal of Infectious Diseases"},{"key":"S095026882200139X_ref11","unstructured":"11. Health Canada (2002) Uses of antimicrobials in food animals in Canada: impact on resistance and human health. Available at https:\/\/www.canada.ca\/content\/dam\/hc-sc\/migration\/hc-sc\/dhp-mps\/alt_formats\/hpfb-dgpsa\/pdf\/pubs\/amr-ram_final_report-rapport_06-27-eng.pdf (Accessed 8 March 2022)."},{"key":"S095026882200139X_ref9","unstructured":"9. World Health Organization (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Available at https:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf (Accessed 13 December 2021)."},{"key":"S095026882200139X_ref32","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/503426","article-title":"Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia","volume":"42","author":"Unicomb","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"S095026882200139X_ref58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10096-001-0673-1","article-title":"Emergence of cotrimoxazole- and quinolone-resistant Campylobacter infections in bone marrow transplant recipients","volume":"21","author":"Lau","year":"2002","journal-title":"European Journal of Clinical Microbiology and Infectious Disease"},{"key":"S095026882200139X_ref31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/516263","article-title":"Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review","volume":"26","author":"Tee","year":"1998","journal-title":"Clinical Infectious Diseases"},{"key":"S095026882200139X_ref54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.medmal.2020.04.013","article-title":"Chronic high-level multidrug-resistant Campylobacter coli enterocolitis in an agammaglobulinemia patient: oral gentamicin efficacy","volume":"50","author":"Dan","year":"2020","journal-title":"Medecine et Maladies Infectieuses"},{"key":"S095026882200139X_ref30","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/598932","article-title":"Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection","volume":"48","author":"Evans","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"S095026882200139X_ref55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jgar.2021.04.029","article-title":"Antimicrobial susceptibility testing and successful treatment of hospitalised patients with extensively drug-resistant Campylobacter jejuni infections linked to a pet store puppy outbreak","volume":"26","author":"Goyal","year":"2021","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"S095026882200139X_ref4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diagmicrobio.2015.07.020","article-title":"Antibiotic susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli in Ontario, Canada during 2011\u20132013","volume":"83","author":"Riley","year":"2015","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"S095026882200139X_ref18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1139\/cjm-2020-0146","article-title":"Rate of fluoroquinolone resistance in domestically acquired Campylobacter jejuni are increasing in people living within a model study location in Canada","volume":"67","author":"Inglis","year":"2020","journal-title":"Canadian Journal of Microbiology"},{"key":"S095026882200139X_ref57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/00365540500372903","article-title":"Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review","volume":"38","author":"Kotilainen","year":"2006","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"S095026882200139X_ref37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3201\/eid1006.030635","article-title":"Antimicrobial resistance among Campylobacter strains, United States, 1997\u20132001","volume":"10","author":"Gupta","year":"2004","journal-title":"Emerging Infectious Diseases"},{"key":"S095026882200139X_ref56","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1442-200x.2000.01280.x","article-title":"Campylobacter jejuni bacteremia in an immunocompetent Japanese child","volume":"42","author":"Kaneko","year":"2000","journal-title":"Pediatrics International"},{"key":"S095026882200139X_ref53","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2169\/internalmedicine.53.2559","article-title":"Clinical features of bacteremia due to Campylobacter jejuni","volume":"53","author":"Mori","year":"2014","journal-title":"Internal Medicine"},{"key":"S095026882200139X_ref36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/dkf173","article-title":"Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad","volume":"50","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"S095026882200139X_ref1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1089\/fpd.2012.1389","article-title":"Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006","volume":"10","author":"Thomas","year":"2013","journal-title":"Foodborne Pathogens and Disease"},{"key":"S095026882200139X_ref20","unstructured":"20. Council of Canadian Academies (2019) When Antibiotics Fail. Available at https:\/\/cca-reports.ca\/wp-content\/uploads\/2018\/10\/When-Antibiotics-Fail-1.pdf (Accessed 8 March 2022)."},{"key":"S095026882200139X_ref28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.sapharm.2016.04.006","article-title":"Comparison of the time-to-indexing in PubMed between biomedical journals according to impact factor, discipline, and focus","volume":"13","author":"Irwin","year":"2017","journal-title":"Research in Social and Administrative Pharmacy"},{"key":"S095026882200139X_ref41","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/428453","article-title":"Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study","volume":"191","author":"Helms","year":"2005","journal-title":"The Journal of Infectious Diseases"},{"key":"S095026882200139X_ref47","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.2105\/AJPH.2013.301867","article-title":"Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005\u20132011","volume":"104","author":"Ricotta","year":"2014","journal-title":"American Journal of Public Health"},{"key":"S095026882200139X_ref13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1089\/fpd.2019.2752","article-title":"Antimicrobial resistance of Campylobacter in broiler chicken along the food chain in Canada","volume":"17","author":"Dram\u00e9","year":"2020","journal-title":"Foodborne Pathogens and Disease"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026882200139X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T08:26:31Z","timestamp":1671092791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026882200139X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":59,"alternative-id":["S095026882200139X"],"URL":"https:\/\/doi.org\/10.1017\/s095026882200139x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Copyright \u00a9 CROWN Copyright \u2013 Her Majesty the Queen in Right of Canada as Represented by the Minister of Health, 2022. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e205"}}